In Mozobil 24 mg, the active substance named plerixafor mainly acts in order to block the activity of CXCR4 chemokine receptor, which normally helps in order to keep the stem cells within the bone marrow. By blocking its activity, Celrixafor helps enable the stem cells to be released into the blood, so that they collect.